Evidence map›Paper›PMID 24237975›Full record

ReviewPediatric clinics of North America2013

Abnormalities of the erythrocyte membrane.

Patrick G Gallagher

Abstract readReview
In one paragraph

Review in Pediatric clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Main events and mechanism of human erythrocyte ageing.Expert reviews in molecular medicine · 2026
    Review
  6. Review
  7. Expanding the genetic landscape ofFrontiers in genetics · 2026
    Article
  8. Article
  9. Article
  10. Biomechanics of phagocytosis of red blood cells by macrophages in the human spleen.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Patrick G GallagherDepartment of Pediatrics, Yale University School of Medicine, 333 Cedar Street, PO Box 208064, New Haven, CT 06520-8064, USA. Electronic address: patrick.gallagher@yale.edu.

Funding

MOLECULAR BIOLOGY OF HUMAN ERYTHROCYTE ALPHA-SPECTRINR01HL065448 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2000 to 2013
$4.4M
NHLBI NIH HHS R01 HL065448
6 · The paper itself

Abstract

Primary abnormalities of the erythrocyte membrane are characterized by clinical, laboratory, and genetic heterogeneity. Among this group, hereditary spherocytosis patients are more likely to experience symptomatic anemia. Treatment of hereditary spherocytosis with splenectomy is curative in most patients. Growing recognition of the long-term risks of splenectomy has led to re-evaluation of the role of splenectomy. Management guidelines acknowledge these considerations and recommend discussion between health care providers, patient, and family. The hereditary elliptocytosis syndromes are the most common primary disorders of erythrocyte membrane proteins. However, most elliptocytosis patients are asymptomatic and do not require therapy.

Indexed as

Anemia, Hemolytic, CongenitalElliptocytosis, HereditaryErythrocyte MembraneErythrocytesHumansSpherocytosis, HereditarySplenectomyAnemiaErythrocyte membraneHereditary elliptocytosisHereditary pyropoikilocytosisHereditary spherocytosisSplenectomy

Identifiers

PMID24237975
PMCPMC4155395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.